Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology